Latest Close
$26.09
News
ADPT
Adaptive Biotechnologies Corpor News
This news view pulls recent coverage and headlines tied to ADPT.
1y Change
$10.44 (+66.71%)
Market Cap
$4.16B
Sector
Healthcare
Industry
Diagnostics & Research
Recommendation
strong_buy
Adaptive Biotechnologies (ADPT) Stock Sees Modest Fair Value Lift On MRD Optimism
Simply Wall St. • Oct 8, 2026
Read articleAdaptive Biotechnologies Insider Sold Shares Worth $1,014,329, According to a Recent SEC Filing
MT Newswires • Oct 6, 2026
Read articleAdaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update
Simply Wall St. • Sep 25, 2026
Read articleAdaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure
GlobeNewswire • Sep 25, 2026
Read articleAdaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now?
Simply Wall St. • Sep 25, 2026
Read articleNCCN’s Myeloma MRD Update Spotlighting clonoSEQ Could Be A Game Changer For Adaptive Biotechnologies (ADPT)
Simply Wall St. • Sep 24, 2026
Read article